|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA02000195
|
2R-hydroxy-stearic acid
|
2R-hydroxy-octadecanoic acid
|
FA 18:0;O
|
C18H36O3
|
300.266446
|
|
LMFA02000195
|
2R-hydroxy-stearic acid
|
2R-hydroxy-octadecanoic acid
|
FA 18:0;O
|
C18H36O3
|
300.266446
|
|
LMFA03140007
|
18S-Resolvin E3
|
17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA03140007
|
18S-Resolvin E3
|
17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA03140007
|
18S-Resolvin E3
|
17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA07050279
|
9-octadecynoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate}
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA07050279
|
9-octadecynoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate}
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA07050279
|
9-octadecynoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate}
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA07050279
|
9-octadecynoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate}
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA07050279
|
9-octadecynoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate}
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA07050279
|
9-octadecynoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate}
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA05000648
|
cis-4-Decenol
|
(4Z)-dec-4-en-1-ol
|
FOH 10:1
|
C10H20O
|
156.151415
|
|
LMFA07070071
|
Hydroxybutyrylcarnitine
|
(3S)-3-[(3-hydroxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 4:0;O
|
C11H21NO5
|
247.141974
|
|
LMFA07070071
|
Hydroxybutyrylcarnitine
|
(3S)-3-[(3-hydroxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 4:0;O
|
C11H21NO5
|
247.141974
|
|
LMFA07010740
|
2-Propenyl 2,4-hexadienoate
|
prop-2-en-1-yl (2E,4E)-hexa-2,4-dienoate
|
WE 9:3
|
C9H12O2
|
152.083730
|
|
LMFA07010740
|
2-Propenyl 2,4-hexadienoate
|
prop-2-en-1-yl (2E,4E)-hexa-2,4-dienoate
|
WE 9:3
|
C9H12O2
|
152.083730
|
|
LMFA05000569
|
(Z)-2-Decene-4,6,8-triyn-1-ol
|
(2E)-dec-2-en-4,6,8-triyn-1-ol
|
FOH 10:7
|
C10H8O
|
144.057515
|
|
LMFA08020201
|
pre-putrebactin
|
4-{[4-({4-[(4-aminobutyl)(hydroxy)amino]-4-oxobutanoyl}amino)butyl](hydroxy)amino}-4-oxobutanoic acid
|
|
C16H30N4O7
|
390.211450
|
|
LMFA07070097
|
O-palmitoleoylcarnitine
|
3-[(9Z)-hexadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070097
|
O-palmitoleoylcarnitine
|
3-[(9Z)-hexadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070045
|
3-hydroxytetradecanoylcarnitine
|
3-[(3-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:0;O
|
C21H41NO5
|
387.298474
|
|
LMFA07070045
|
3-hydroxytetradecanoylcarnitine
|
3-[(3-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:0;O
|
C21H41NO5
|
387.298474
|
|
LMFA07070076
|
Isovalerylcarnitine
|
3-[(3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 5:0
|
C12H23NO4
|
245.162709
|
|
LMFA07070076
|
Isovalerylcarnitine
|
3-[(3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 5:0
|
C12H23NO4
|
245.162709
|
|
LMFA07010746
|
2-Propenyl heptanoate
|
prop-2-en-1-yl heptanoate
|
WE 10:1
|
C10H18O2
|
170.130680
|
|
LMFA07010746
|
2-Propenyl heptanoate
|
prop-2-en-1-yl heptanoate
|
WE 10:1
|
C10H18O2
|
170.130680
|
|
LMFA07010694
|
(+/-)-Ethyl 2-hydroxy-3-methylvalerate
|
ethyl 2-hydroxy-3-methylpentanoate
|
SFE 8:0;O
|
C8H16O3
|
160.109945
|
|
LMFA07010694
|
(+/-)-Ethyl 2-hydroxy-3-methylvalerate
|
ethyl 2-hydroxy-3-methylpentanoate
|
SFE 8:0;O
|
C8H16O3
|
160.109945
|
|
LMFA07010694
|
(+/-)-Ethyl 2-hydroxy-3-methylvalerate
|
ethyl 2-hydroxy-3-methylpentanoate
|
SFE 8:0;O
|
C8H16O3
|
160.109945
|
|
LMFA08020179
|
gamma-sanshool
|
N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide
|
NA 18:5
|
C18H27NO
|
273.209264
|
|
LMFA08020179
|
gamma-sanshool
|
N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide
|
NA 18:5
|
C18H27NO
|
273.209264
|
|
LMFA08020179
|
gamma-sanshool
|
N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide
|
NA 18:5
|
C18H27NO
|
273.209264
|
|
LMFA07010788
|
Ascorbyl palmitate
|
2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate
|
WE 22:3;O5
|
C22H38O7
|
414.261756
|
|
LMFA07010788
|
Ascorbyl palmitate
|
2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate
|
WE 22:3;O5
|
C22H38O7
|
414.261756
|
|
LMFA07010788
|
Ascorbyl palmitate
|
2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate
|
WE 22:3;O5
|
C22H38O7
|
414.261756
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA07050237
|
3-oxoadipyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:2;O3
|
C27H42N7O20P3S
|
909.141819
|
|
LMFA01030504
|
2-nonynoic acid
|
2-nonynoic acid
|
FA 9:2
|
C9H14O2
|
154.099380
|
|
LMFA04020268
|
(4S,8S,11R)-d5-7-NeuroF[7R,10R]
|
(S,E)-4-hydroxy-6-((2R,3S,5R)-3-hydroxy-5-((R,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA07010883
|
Ethyl stearate
|
ethyl octadecanoate
|
SFE 20:0
|
C20H40O2
|
312.302831
|
|
LMFA07010848
|
Ethyl (E)-2-octenoate
|
ethyl (2Z)-oct-2-enoate
|
SFE 10:1
|
C10H18O2
|
170.130680
|
|
LMFA07010848
|
Ethyl (E)-2-octenoate
|
ethyl (2Z)-oct-2-enoate
|
SFE 10:1
|
C10H18O2
|
170.130680
|
|
LMFA07010961
|
Methyl heptanoate
|
methyl heptanoate
|
SFE 8:0
|
C8H16O2
|
144.115030
|
|
LMFA07010792
|
Butyl butyryllactate
|
1-butoxy-1-oxopropan-2-yl butanoate
|
SFE 11:1;O2
|
C11H20O4
|
216.136160
|
|
LMFA04020204
|
(7S,11S,14R)-d8-10-NeuroF[10R,13R]
|
(S,4Z,8E)-7-hydroxy-9-((2R,3S,5R)-3-hydroxy-5-((R,3Z,6Z)-1-hydroxynona-3,6-dien-1-yl)tetrahydrofuran-2-yl)nona-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|